Analysts are backing Take-Two Interactive harder after fresh target price upgrades this week. The consensus now sits overwhelmingly bullish. 28 of 30 analysts rate the stock a Buy. The average target price moved up to $279.45.
Accenture is heading the other way. Analysts trimmed their average target price from $208 to $197. The consulting giant carries a $78.5 billion market cap. The downward move adds to pressure on the IT services sector.
Lithium specialist Albemarle saw its average target nudge up to $214.65. Short interest sits at 9.1% of free float. That elevated short position means any bullish analyst momentum could trigger a squeeze.
Eli Lilly also picked up a target raise. Average analyst target now stands at $1,218. With 22 Buy ratings versus just one Sell, the pharma giant remains a Wall Street favourite.
Lululemon faced downward target revisions. The average target slipped to $132.16. Two analysts rate it a Sell — unusual for an apparel name with 30 Holds sitting below.
Boston Scientific saw a modest target cut as well. At $76.48 average, its 26 Buy ratings still show strong underlying confidence in the medtech space.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
